Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
An anomaly was discovered in which a second or subsequent user can access a patient record which is already open at another workstation and if they ignore the warning the message that the record is being edited by another user and proceed to edit the plan and save the record a corrupted but usable patient plan record may result. errors can include but are not limited to incorrect mu incorrect beam modifiers incorrect gantry angles incorrect field sizes etc.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
An alert message on the spectral filtration of the x-ray beam is possibly not managed appropriatly at the time of its appearance during the daily calibration of the system.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
A method comparison across all inhibin a formats and calibrations conducted revealed a +30% difference in patient dose response for the elisa kit when compared to the access.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
There are confirmed customer complaints of low patient sample recovery with dimension tacr flex reagent cartridge lot bb4087 and its linked calibrator lot 3bd029. quality control (qc) materials have not exhibited recovery outside of the expected range. internal complaint testing versus our reference lc/ms method confirmed an average bias of -1.6 ng/ml [-2.1 nmol/l] across the assay range. individual patients particularly samples with lower tacr values (< 5 ng/ml [6.5 nmol/l]) may show more bias due to the typical precision of each methodology.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
There is a potential safety risk related to patient treatment when using the portal review application of the syngo rt therapist. as a consequence of this risk an incorrect offset may be applied for patient positioning and thus may result in a mistreatment (dose to wrong location).
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
When printing multiple drr's and "print displayed drr" is set to yes (file-print-drr) only the first beam is printed correctly. under certain conditions the wrong area might be treated (see 33-02).
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
Under certain conditions the series could be incorrectly labeled in image view which could lead to under-treatment of a tumor.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
A system error may occur which results in unintended movement during examination.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
The model 8840 physician programmer may display an incorrect "schedule to replace the pump by" date for the model 8637 synchromed ii implantable drug infusion pump. in some circumstances after a pump's eri has occurred the date may be displayed as a series of question marks or as a date greater than 90 days from the eri date potentially leading to the pump reaching end of service prior to replacement. this issue may only occur if the 90days after eri notification falls on the first day of a month. it does not affect pump function or alarms. this is due to a software error specific to the model 8870 application card software for the synchromed ii pump.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
There were some field reports related to receipt of the expired product atp-54 angio touch controller kit lot 07516n (date d'expiration: 2017-03-29).
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
It has been discovered that the feature "exit conditioning" may cause a risk to patients. when a new sensor cassette is installed the analyzer will automatically run extra calibrations and internal qc's for the first 24 hours. it is possible during sensor cassette start-up to press "exit conditioning". this will cancel the second start-up calibration and the 3 start-up qc's. it will not affect the remaining frequent calibrations. the analyzer does not indicate the exit from the conditioning and the patient results are not flagged for qc not being run.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
`incidents of gantry collisions with patients operating during remote and manual mode motion have been identified. this action does not pertain to truebeam devices.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
On the cumulative result report of td-synergy previous results following a specific sequence of events are printed even though they have not been clinically reviewed. it only applies to sites using cumulative result reports by department.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
Measurement values provided by seno advantage workstations 1x 2.0 & 2.1 may be incorrect when applied to magnification images acquired on non-ge digital mammography systems which could lead to overestimate of size of breast lesion.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
Reports regarding weak.Open seals on the convenience paks (trays). condition can adversely impact pak sterility.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
Internal testing has confirmed a low absorbance with ptn flex lot fa5154 resulting in the potential for a positive or negative bias and imprecision across the ptn assay range. internal studies demonstrate the bias is variable across the assay range from 9-38%. the highest degree of bias is observed below the therapeutic range of 10-20 ug/ml (39.6-79.2 umol/l). the reagent blank absorbance for ptn lot fa5154 may also generate abnormal reaction flags. the issue may be detected by qc or failed calibrations. if undetected by qc it may manifest as inaccuracy or imprecision with patient samples.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
Labelling error. portuguese instructions for preparation indicate to add 12.9g of cm0895 to one litre of water. correct amount of water should be 225ml.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
False-negative lipa results can occur with elevated lipase activities of 1000 u/l when the product has been stored on a vitros chemistry system for more than 48 hours.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
There is an increased user/patient risk of exposure to fire and/or electrical shock due to the failure of the prn 50-m+ digital writer to meet its intended flammability and fluid ingress rating.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
Real time controller - hard disk replacement -- also see recalls 024225 and 024228 for the involved serial numbers.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
Software anomaly in version 4.1 4.2 and 4.3 which may lead allow results to be placed with an incorrect sample id.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
Notes supplémentaires dans les données
Cause
Lots manufactured with a prior version of the guidewire lumen material which is not validated with the current manufacturing process separated unretrieved fragments may embolize and cause vessel occulusion.
Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
The Parent Company and the Product Classification were added by ICIJ.
The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.